Entact Bio is developing a novel class of precision medicines that enhance the function of beneficial proteins. Launched by a founding team deeply rooted in deubiquitylase (DUB) biochemistry, chemical biology, disease biology, and small-molecule drug development, Entact has built its proprietary Encompass™ platform to create enhancement-targeting chimeric (ENTAC™) medicines. ENTACs leverage the natural ability of DUBs to regulate and enhance protein function. By harnessing the power of DUBs, Entact is expanding the universe of treatable diseases and creating new options for patients who are underserved by current therapeutic modalities.
Company Details
- Employees
- 34
- Address
- Watertown, Massachusetts 02472, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://entactbio.com
- Keywords
- Engineer jobs.
- HQ
- Watertown, Massachusetts
Entact Bio Questions
Entact Bio's website is http://entactbio.com
Entact Bio's LinkedIn profile is https://www.linkedin.com/company/entact-bio
Entact Bio has
34 employees.
View email and phone details for 34
employees at Entact Bio.
Entact Bio's industry is
Biotechnology Research
Entact Bio's top competitors are
Dunad Therapeutics,
Ribon Therapeutics,
Vicinitas Therapeutics,
Stablix, Inc.,
Moma Therapeutics,
Stellular Bio,
Nested Therapeutics,
Triana Biomedicines,
Rome Therapeutics,
Kymera Therapeutics.
Entact Bio's categories are Biotechnology Research
